24HourWire
News from all angles
MedPage Today
Center
Late-Stage Sickle Cell Disease Study Splits on Main Goals
(MedPage Today) -- The thalassemia drug mitapivat (Aqvesme) significantly improved hemoglobin response in patients with sickle cell disease but failed to top placebo when it came to reducing pain cri…